Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study.

Autor: Straube A; Department of Neurology, University Hospital, LMU Munich, Munich, Germany. Andreas.Straube@med.uni-muenchen.de., Broessner G; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Gaul C; Headache Center Frankfurt, Frankfurt, Germany., Hamann X; Teva GmbH, Ulm, Germany., Hipp J; Teva GmbH, Ulm, Germany., Kraya T; Department of Neurology, Hospital Sankt Georg Leipzig gGmbH, Leipzig, Germany.; Department of Neurology, Headache Center Halle, University Hospital Halle, Halle (Saale), Germany., Neeb L; Helios Global Health, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Publikováno v: The journal of headache and pain [J Headache Pain] 2023 May 23; Vol. 24 (1), pp. 59. Date of Electronic Publication: 2023 May 23.

1816P - Prophylaxis with lipegfilgrastim in patients with primary breast cancer receiving dose dense chemotherapy: Results from the German NIS NADENS

Autor: Kiechle, M. ¹, Schem, C. ², Lüftner, D. ³, Hamann, X. ⁴, Jünemann, R. ⁴, Tölg, M. ⁵, Köhler, U. ⁶

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v738-v738

Efficacy of galcanezumab in migraine central sensitizatio.

Autor: Danno, Daisuke¹ (AUTHOR) daisukedanno@yahoo.co.jp, Imai, Noboru² (AUTHOR), Kitamura, Shigekazu³ (AUTHOR), Ishizaki, Kumiko¹ (AUTHOR), Kikui, Shoji¹ (AUTHOR), Takeshima, Takao¹ (AUTHOR)

Publikováno v: Scientific Reports. 9/18/2024, Vol. 14 Issue 1, p1-12. 12p.

Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany.

Autor: Kaplan S; a Teva Pharmaceutical Industries Ltd , Netanya , Israel., Ehlken B; b IQVIA (formerly IMS Health) , Munich , Germany., Hamann X; c Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2019 Aug; Vol. 35 (8), pp. 1397-1403. Date of Electronic Publication: 2019 Apr 23.